Cargando…
Stem cells and beta cell replacement therapy: a prospective health technology assessment study
BACKGROUND: Although current beta cell replacement therapy is effective in stabilizing glycemic control in highly selected patients with refractory type 1 diabetes, many hurdles are inherent to this and other donor-based transplantation methods. One solution could be moving to stem cell-derived tran...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791348/ https://www.ncbi.nlm.nih.gov/pubmed/29382312 http://dx.doi.org/10.1186/s12902-018-0233-7 |